WCTD2016 Abstract Topics Design a Clinical Program for Success (17 abstracts)
Patient preference for using computers, smartphones, and internet to participate in diabetes clinical trials
Khurana Laura 1 , Ellen M Durand 1 , Sarah Tressel Gary 1 , Antonio V Otero 1 , Chris Hall 1 , Kelsey Berry 2 , Christopher J Evans 2 & Susan M Dallabrida 1
1Clinical Science & Consulting, ERT, USA; 2Research, Endpoint Outcomes, USA.
Background: Patient engagement and adherence are critical to the success of clinical trials. Electronic patient-reported outcomes (ePROs) are increasingly used to evaluate diabetes clinical trial endpoints. This study characterized how subjects prefer to use various types of technology to report ePROs in a clinical trial. Considering patient preference during diabetes trial design may reduce patient burden and improve patient engagement.
Methods: 102 subjects with type 2 diabetes were surveyed regarding their preferences for using computers, smartphones, and internet in clinical trials.
Results: Subjects were diverse in age, sex, ethnicity, and technology use. 66% reported having a computer at home, 53% reported using the internet daily, and 48% reported owning a smartphone. Subjects reported that they would be willing to participate in a clinical trial using the internet for up to 1 month (19%), 2–6 months (25%), 1–2 years (17%), or 5+ years (18%). Similarly, subjects were willing to participate in a clinical trial using a smartphone for up to 1 month (19%), 2–6 months (29%), 1–2 years (11%), or 5+ years (18%). When asked what time of day they would prefer to complete a daily electronic diary, subjects preferred 8pm-midnight (32%), 8am-noon (19%) or noon-4pm (15%). Subjects thought it would be necessary (16%) or helpful (74%) to have an audible alarm to remind them to record their symptoms. In a multi-select question, subjects preferred to report their symptoms once a day for a clinical trial using a paper form (55%), an interactive voice system (51%), or a web-based form on the internet (49%).
Conclusions: Diabetes subjects are willing to use computers, smartphones, and internet in a clinical trial setting. Trial sponsors should consider patient preferences for specific technology features to reduce patient burden and improve engagement and adherence when using ePRO assessments.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more